Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study-Reference-Cited by-同舟云学术

Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study

Published:2022-01-18 Issue:6 Volume:18 Page:578-585
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Maeda Osamu¹^ORCID,Fukaya Masahide²,Koike Masahiko³,Miyata Kazushi²^ORCID,Kanda Mitsuro³^ORCID,Nishida Kazuki⁴^ORCID,Ando Masahiko⁴,Kodera Yasuhiro³^ORCID,Ando Yuichi¹^ORCID

Affiliation:

1. Department of Clinical Oncology and Chemotherapy Nagoya University Hospital Nagoya Japan

2. Division of Surgical Oncology, Department of Surgery Nagoya University Graduate School of Medicine Nagoya Japan

3. Department of Gastroenterological Surgery (Surgery II) Nagoya University Graduate School of Medicine Nagoya Japan

4. Center for Advanced Medicine and Clinical Research Nagoya University Hospital Nagoya Japan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13755

Reference24 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life‐years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study;Fitzmaurice C;JAMA Oncol,2019

2. Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204

3. A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

4. Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus

5. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of pegfilgrastim on day 3 of preoperative docetaxel, cisplatin and 5-fluorouracil chemotherapy in elderly patients with resectable esophageal cancer;2024-01-24

2. Risk factors for venous thrombosis after esophagectomy;Esophagus;2024-01-12

3. Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer;Cancer Medicine;2024-01

4. Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients;International Journal of Clinical Oncology;2023-12-08

5. Risk Factors for Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer;Anticancer Research;2023-02-28